U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
110011110011Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and OfatumumabTerminatedNo Results AvailableChronic Lymphocytic Leukemia (CLL)Drug: ofatumumab + bendamustinehttps://ClinicalTrials.gov/show/NCT01125787
110012110012Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)CompletedHas ResultsMigraineDrug: Telcagepant|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01125774
110013110013Efficacy and Safety of the Association of Dexamethasone 0.5 mg + Clemastine Fumarate 1 mg When Compared to Dexamethasone 0.5 mg in Patients With Allergic DermatitisWithdrawnNo Results AvailableDermatitisDrug: dexamethasone 0.5 mg and 1.0 mg clemastine cream|Drug: Dexamethasone 0,5 mg creamhttps://ClinicalTrials.gov/show/NCT01125761
110014110014A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term TherapyCompletedHas ResultsAllergic AsthmaDrug: Omalizumab|Drug: Placebo|Drug: Asthma therapieshttps://ClinicalTrials.gov/show/NCT01125748
110015110015MIST Therapy's Effectiveness in Wound Bed Preparation and Role of Bacterial Biofilm in Chronic, Non-healing WoundsWithdrawnNo Results AvailableChronic Nonhealing WoundsDevice: MIST Therapy|Other: Standard of Carehttps://ClinicalTrials.gov/show/NCT01125735
110016110016Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)CompletedHas ResultsOveractive BladderDevice: Non-invasive neurostimulation device|Device: Non-invasive neurostimulation devicehttps://ClinicalTrials.gov/show/NCT01125722
110017110017Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS)CompletedNo Results AvailableDuchenne Muscular Dystrophyhttps://ClinicalTrials.gov/show/NCT01125709
110018110018Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBVRecruitingNo Results AvailableHIV|Hepatitis BDrug: Tenofovir/lamivudine/lopinavir-ritonavir|Drug: Zidovudine/lamivudine/lopinavir-ritonavirhttps://ClinicalTrials.gov/show/NCT01125696
110019110019To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's DiseaseTerminatedNo Results AvailableAlzheimer´s DiseaseDrug: AZD1446|Drug: Donepezil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01125683
110020110020A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 TabletCompletedNo Results AvailableHealthy Volunteer|Pharmacokinetics of YM150Drug: YM150https://ClinicalTrials.gov/show/NCT01125670
110021110021A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-BCompletedNo Results AvailableHealthy Volunteer|Pharmacokinetics of YM150Drug: YM150https://ClinicalTrials.gov/show/NCT01125657
110022110022Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary MycosisRecruitingNo Results AvailableCryptococcosis or Aspergillosis InfectionsDrug: SPK-843https://ClinicalTrials.gov/show/NCT01125644
110023110023Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseBiological: PF-04360365 8.5 mg/kg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01125631
110024110024The Millennium Villages Project: Assessing the Impact on Child Survival and the Millennium Development Goals in Sub-Saharan AfricaRecruitingNo Results AvailableChild SurvivalOther: Health and development intervention package|Other: Routine serviceshttps://ClinicalTrials.gov/show/NCT01125618
110025110025PASCONAL NERVENTROPFEN in the Treatment of Nervous DiseasesCompletedHas ResultsNervousness|Sleep Disordershttps://ClinicalTrials.gov/show/NCT01125605
110026110026Assessment of the Ability of Ionic Foot Bath (IonCleanse®) to Remove Heavy Metals Through the Feet and Its Potential Impact on Body Burden of Heavy MetalsCompletedNo Results AvailableHealthyDevice: IonCLeanse Footbathhttps://ClinicalTrials.gov/show/NCT01125592
110027110027Effectiveness of NEURAPAS Balance in Children With Nervous RestlessnessCompletedNo Results AvailableNervousness|Restlessness|Depression (Agitated)|Affective Disordershttps://ClinicalTrials.gov/show/NCT01125579
110028110028LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin TreatmentActive, not recruitingHas ResultsBreast NeoplasmsDrug: BIBW 2992|Drug: trastuzumab|Drug: vinorelbine|Drug: vinorelbinehttps://ClinicalTrials.gov/show/NCT01125566
110029110029A Comparison Between Two Formulations of NN5401 in Healthy SubjectsCompletedNo Results AvailableDiabetes|HealthyDrug: insulin degludec/insulin asparthttps://ClinicalTrials.gov/show/NCT01125553
110030110030The Role of Daily Disposable Contact Lenses in Ocular AllergyCompletedNo Results AvailableGrass Pollen Ocular AllergyDevice: Acuvue (Standard Daily Disposable Contact Lens)|Device: CIBA Dailies Aquacomfort Plus (Contact Lens - enhance lubricating)https://ClinicalTrials.gov/show/NCT01125540
110031110031Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy ChildrenCompletedNo Results AvailableHaemophilus Influenzae Type b (Hib) InfectionBiological: Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)|Biological: Tetanus toxoid polysaccharide-conjugated vaccine against Haemophilus influenzae type b (Hib)https://ClinicalTrials.gov/show/NCT01125527
110032110032A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart FailureCompletedHas ResultsHeart FailureDrug: Aliskiren 150 mg|Drug: Furosemide 60 mg|Drug: Placebo for Aliskiren|Drug: Aliskiren 300 mghttps://ClinicalTrials.gov/show/NCT01125514
110033110033Protandim and the Metabolic SyndromeWithdrawnNo Results AvailableMetabolic SyndromeDietary Supplement: Protandimhttps://ClinicalTrials.gov/show/NCT01125501
110034110034Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative SurgeryRecruitingNo Results AvailableEndometriosisDevice: LNG-IUS|Drug: GnRH agonist (triptorelin)https://ClinicalTrials.gov/show/NCT01125488
110035110035A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) SubjectsCompletedNo Results AvailableRelapsing Remitting Multiple Sclerosis (RRMS)Device: RebiSmarthttps://ClinicalTrials.gov/show/NCT01125475
110036110036A Post Marketing Assessment of Gonal f Solution for Injection in a Prefilled Pen for Follicular Stimulation in in Vitro Fertilisation/Embryo Transfer (IVF-ET) CyclesCompletedNo Results AvailableInfertilityOther: Quality of Life Questionnaire (FertiQoL)https://ClinicalTrials.gov/show/NCT01125462
110037110037Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor DiseaseSuspendedNo Results AvailableSarcoma|Adenocarcinoma|Carcinoma|Multiple Myeloma|Desmoplastic Small Round Cell TumorDrug: Ascorbic acid (vitamin C)https://ClinicalTrials.gov/show/NCT01125449
110038110038A Trial of Vitamin D Therapy in Patients With Heart FailureActive, not recruitingNo Results AvailableHeart Failure|Aerobic Capacity|StrengthDietary Supplement: Cholecalciferol|Dietary Supplement: Cholecalciferolhttps://ClinicalTrials.gov/show/NCT01125436
110039110039Study of Fibromyalgia Treated With MilnacipranRecruitingNo Results AvailableFibromyalgiaDrug: Milnacipran|Procedure: Skin biopsyhttps://ClinicalTrials.gov/show/NCT01125423
110040110040Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial VaginosisCompletedNo Results AvailableBacterial VaginosisDrug: Dequalinium chloride|Drug: Clindamycinhttps://ClinicalTrials.gov/show/NCT01125410

* Görseller ve İçerik tekif hakkına sahip olabilir